A detailed history of Cardinal Point Capital Management, Ulc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cardinal Point Capital Management, Ulc holds 403 shares of LLY stock, worth $362,212. This represents 0.06% of its overall portfolio holdings.

Number of Shares
403
Previous 399 1.0%
Holding current value
$362,212
Previous $310 Million 17.55%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $2,899 - $3,636
4 Added 1.0%
403 $365 Million
Q1 2024

Apr 24, 2024

BUY
$592.2 - $792.28 $1,776 - $2,376
3 Added 0.76%
399 $310 Million
Q4 2023

Jan 12, 2024

SELL
$525.19 - $619.13 $68,274 - $80,486
-130 Reduced 24.71%
396 $231 Million
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $228,652 - $315,231
526 New
526 $283 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $854B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cardinal Point Capital Management, Ulc Portfolio

Follow Cardinal Point Capital Management, Ulc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Point Capital Management, Ulc, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Point Capital Management, Ulc with notifications on news.